Rising Pharmaceuticals will unveil the first generic version of the Ultramicrosize Griseofulvin tablets USP 25mg and 250mg strengths, which are an FDA approved generic version of PEDiNOL Pharmacal's Gris-PEG(R).
Used to treat fungus infections, the Ultramicrosize Griseofulvin tablets had sales nearly of $16.7m for the twelve months ended 30 June 2012 in the US market, according to IMS Health data.
Rising Pharmaceuticals is a finished dosage form generics subsidiary of ACETO Corporation, which markets, sells and distributes products for human health, pharmaceutical ingredients and performance chemicals.
Source:
http://drugdiscovery.pharmaceutical-business-review.com/news/rising-pharmaceuticals-to-launch-generic-version-of-gris-pegr-201112
